Recessive Dystrophic Epidermolysis Bullosa Skin Displays a Chronic Growth-Activated Immunophenotype
- 1 January 1990
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 126 (1), 78-83
- https://doi.org/10.1001/archderm.1990.01670250084014
Abstract
• Epidermolysis bullosa represents a grouping of inherited skin diseases characterized by epidermal fragility and frequently wounded skin. The recessive dystrophic subtype of epidermolysis bullosa (RDEB) is characterized by extensive dermal scarring after healing of repeated epidermal injuries and by an unusually high incidence of squamous cell carcinoma occurring in chronically wounded skin. In contrast, the simplex form of epidermolysis bullosa usually heals without scarring and does not predispose to malignant neoplasms of the skin. The differences in scarring and the neoplastic potential of these two forms of epidermolysis bullosa prompted us to investigate growth activation and differentiation characteristics in epidermal keratinocytes in individuals with these disorders. The expression of filaggrin, involucrin, cytokeratins, and the growth activation marker psi-3 was examined by immunohistochemistry in skin biopsy specimens from four individuals with epidermolysis bullosa simplex and six individuals with RDEB. Previous experiments using this technique have demonstrated that these antibodies are good markers for identifying growth-activated keratinocytes in wounded and hyperplastic epidermis. All biopsy specimens of healed wounds in skin from patients with RDEB showed epidermis that reacted with antibodies to filaggrin, involucrin, specific cytokeratins, and psi-3 in a growth-activated pattern. This growth-activated phenotype was maintained in keratinocytes from previously wounded skin that had been healed for more than 2 years. The RDEB growth-activated phenotype detected by immunohistochemistry was not associated with microscopically detectable epidermal hyperplasia. In contrast, all cases of epidermolysis bullosa simplex examined showed an epidermal phenotype similar to that of keratinocytes in normal skin. Thus, healing with dermal scar formation in RDEB is associated with a persistent growth-activated immunophenotype of epidermal keratinocytes. This chronic growth activation state or failure of cells to differentiate in a normal fashion may be directly linked to the high incidence of squamous cell cancers in individuals with RDEB. (Arch Dermatol. 1990;126:78-83)Keywords
This publication has 16 references indexed in Scilit:
- An Assessment of Human Epidermal Repair in Elderly Normal Subjects Using Immunohistochemical MethodsJournal of Investigative Dermatology, 1988
- Tissue stress and tumor promotion. Possible relevance to epidermolysis bullosaArchives of Dermatology, 1988
- Changes in Keratinocyte Maturation During Wound HealingJournal of Investigative Dermatology, 1987
- Keratoacanthoma and squamous cell carcinoma of the skin: Immunohistochemical localization of involucrin and keratin proteinsJournal of the American Academy of Dermatology, 1986
- Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodiesThe Journal of cell biology, 1982
- The cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross-linked proteinCell, 1977
- Epidermolysis bullosa dystrophica and epithelioma of the skin.Review of published cases and report of an additional patientCancer, 1974
- Epidermoid Carcinomas Of Lower ExtremitiesArchives of Surgery, 1964
- Malignancy in scars, chronic ulcers, and sinusesJournal of Clinical Pathology, 1963
- Carcinoma Arising in Scars, Osteomyelitis, and FistulaeArchives of Surgery, 1960